Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.42 USD | +3.40% | +18.04% | -3.86% |
05-01 | Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts | MT |
05-01 | Transcript : TG Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.86% | 2.3B | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- TGTX Stock
- News TG Therapeutics, Inc.
- TG Therapeutics : Says Multiple Sclerosis Drug 'Well Tolerated' in Phase 3 Trials, Plans Regulatory Filing in Q3